Form 4: Kiromic Biopharma CFO Brian Hungerford Acquires 2,000 Shares

Brian Hungerford, CFO of Kiromic Biopharma, recently purchased 2,000 shares of the company's common stock at a price of $1.75 per share.

Summary

• On August 13, 2024, Brian Hungerford, the Chief Financial Officer of Kiromic Biopharma Inc., acquired 2,000 shares of common stock.
• The purchase price was $1.75 per share.
• Following this transaction, Hungerford directly owns 60,933 shares of Kiromic Biopharma Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CFO's purchase could indicate confidence, but it's a relatively small transaction.

Positives

• The CFO's purchase of company stock may signal confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future performance. Purchases by executives are often seen as a positive sign.

Stakeholder Impact

• The stock purchase by the CFO could have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Kiromic Biopharma, Brian Hungerford, CFO, stock purchase, Form 4, KRBP, insider trading